Treatment

APOL1 Genotyping Clinical Trial Assay clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
This study is testing a new drug, AZD2373, for a specific type of kidney disease called APOL1-Mediated Kidney Disease. It's looking at how well the drug works and if it's safe in people aged 18-65 with this condition.
For: APOL1-Mediated Kidney Disease
United States · United Kingdom